Santen Pharmaceutical Co. Ltd.

SNPHY | OTC

Price Alert Chart Builder DCF Calculator

$11.23

+$0.45 (+4.17%)

At close: Oct 30, 2026, 3:15 PM ET

$11.23

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 31, 2026	FY 2025 Mar 31, 2025	FY 2024 Mar 31, 2024	FY 2023 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021
Net Income	37.36B	36.25B	26.64B	-14.96B	27.22B	9.32B
Depreciation & Amortization	18.36B	17.95B	18.18B	17.25B	17.06B	17.92B
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-988M	78M	1.07B	-2.56B	-4.06B	-11.33B
Other Non-Cash Items	569M	933M	12.14B	41.31B	-90M	30.06B
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-12.79B	5.8B	15.7B	-6.46B	1.85B	-18.48B
Operating Cash Flow	43.5B	60.93B	72.65B	37.15B	46.04B	38.81B
Capital Expenditures	-6.84B	-6.66B	-9.32B	-17.28B	-17.34B	-4.14B
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-23.83B
Purchase of Investments	-212M	-1.58B	-508M	-4.06B	-4.04B	-8.73B
Sales Maturities Of Investments	572M	4.73B	4.13B	2.15B	3.87B	3.07B
Other Investing Acitivies	932M	-356M	923M	-279M	838M	-54M
Investing Cash Flow	-12.97B	-8.22B	-6.15B	-26.78B	-35.17B	-53.36B
Debt Repayment	n/a	-158M	-2.11B	4.36B	20.46B	-2.69B
Common Stock Repurchased	-32.8B	-37.88B	-16.96B	-26.01B	n/a	n/a
Dividend Paid	-12.64B	-12.11B	-11.88B	-12.61B	-11.99B	-11.19B
Other Financial Acitivies	-3.91B	-3.16B	-3.08B	-2.97B	-2.91B	-2.8B
Financial Cash Flow	-49.35B	-53.31B	-34.03B	-37.22B	5.56B	-16.69B
Net Cash Flow	-12.12B	-1.59B	36.68B	-25.11B	20.13B	-28.54B
Free Cash Flow	36.66B	54.27B	63.33B	19.87B	28.7B	34.67B
Adj. Free Cash Flow	36.66B	54.27B	63.33B	19.87B	28.7B	34.67B
Maintenance CapEx	-6.84B	-6.66B	-5.1B	-15.11B	-14.77B	-2.95B
Growth CapEx	n/a	n/a	-4.22B	-2.17B	-2.58B	-1.19B
Owner Earnings	36.66B	54.27B	67.55B	22.04B	31.28B	35.86B